Treatment of mycosis fungoides and Sézary syndrome with romidepsin: a series of 32 cases from the French Study Group for Cutaneous Lymphoma

Br J Dermatol. 2019 Feb;180(2):423-424. doi: 10.1111/bjd.17269. Epub 2018 Nov 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibiotics, Antineoplastic / administration & dosage*
  • Antibiotics, Antineoplastic / adverse effects
  • Depsipeptides / administration & dosage*
  • Depsipeptides / adverse effects
  • Disease Progression
  • Follow-Up Studies
  • France / epidemiology
  • Humans
  • Infusions, Intravenous
  • Mycosis Fungoides / diagnosis
  • Mycosis Fungoides / drug therapy*
  • Progression-Free Survival
  • Severity of Illness Index
  • Sezary Syndrome / diagnosis
  • Sezary Syndrome / drug therapy*
  • Sezary Syndrome / mortality
  • Skin / drug effects
  • Skin / pathology
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / mortality
  • Time Factors

Substances

  • Antibiotics, Antineoplastic
  • Depsipeptides
  • romidepsin